NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats

European Journal of Pharmacology

Volumn 299, Issue 1-3, 1996, Pages 83-91

  Biggs, Christopher S ^a   Fowler, Leslie J ^a   Whitton, Peter S ^a   Starr, Michael S ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Dopamine; Glutamate receptor antagonist; Microdialysis; Parkinsonism; Reserpine

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; DIZOCILPINE; DOPAMINE; HOMOVANILLIC ACID; LEVODOPA; METIROSINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; POTASSIUM ION; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; DRUG POTENTIATION; FACILITATION; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA;

EID: 0029932855     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00837-3     Document Type: Article

References (42)

1. Albin, R.L., A.B. Young and J.B. Penney, 1989, The functional anatomy of basal ganglia disorders, Trends Neurosci. 12, 366.
2. Bergman, H., T. Wichmann and M.R. DeLong, 1990, Reversal of experimental parkinsonism by lesions of the subthalamic nucleus, Science 249, 1436.
3. Biggs, C.S., L.J. Fowler, B.R. Pearce and P.S. Whitton, 1992, Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine and their metabolites in the rat brain: an in vivo microdialysis study, J. Neurochem. 59, 1702.
4. 2 and N-methyl-D-aspartate receptors regulate dopamine synthesis in rat striatal synaptosomes, J. Neurochem. 56, 1983.
5. 2 dopamine receptor classification and its functional implications, Synapse 1, 347.
6. Dluzen, D.E. and B. Liu, 1994, The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats, J. Neural Transm. [Gen. Sect.] 95, 209.
7. Elverfors, A. and H. Nissbrandt, 1991, Reserpine-insensitive dopamine release in the substantia nigra?, Brain Res. 557, 5.
8. Fairbrother, I.S., G.W. Arbuthnott, J.S. Kelly and S.P. Butcher, 1990, In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals. II. Studies using potassium and tyramine, J. Neurochem. 54, 1844.
9. 1-mediated turning behavior and striatal c-fos expression by the substantia nigra, Synapse 19, 233.
10. 2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801, J. Neural Transm. [P-D Sect.] 4, 15.
11. Groves, P.M. and J.C. Linder, 1983, Dendro-dendritic synapses in substantia nigra: descriptions based on analysis of serial sections, Exp. Brain Res. 49, 209.
12. Hadjiconstantinou, M., T.A. Wemlinger, C.P. Sylvia, J.P. Hubble and N.H. Neff, 1993, Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors, J. Neurochem. 60, 2175.
13. Kalivas, P.W. and P. Duffy, 1991, A comparison of axonal and somatodendritic dopamine release using in vivo dialysis, J. Neurochem. 56, 961.
14. 1 receptor mechanisms in the potentiation of motor responses to L-DOPA and apomorphine by MK 801 in the reserpine-treated mouse, J. Neural Transm. [P-D Sect.] 8, 107.
15. Klockgether, T and L. Turski, 1989, Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease, Trends Neurosci. 12, 285.
16. Klockgether, T. and L. Turski, 1990, NMDA receptor antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats, Ann. Neurol. 28, 539.
17. König, J.F.R. and R.A. Klippel, 1963, The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem (Williams and Wilkins, Baltimore, MD).
18. Maj, J., Z. Rogoz and G. Skuza, 1993, Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice. Pol. J. Pharmacol. 45, 349.
19. Maurice, T., J. Vignon, J.-M. Kamenka and R. Chicheportiche, 1991, Differential interaction of the phencyclidine-like drugs with the dopamine uptake complex in vivo, J. Neurochem. 56, 553.
20. Mizoguchi, K., H. Yokoo, M. Yoshida, T. Tanaka and M. Tanaka, 1993, Dopamine formation from L-DOPA administered exogenously is independent of dopaminergic neuronal activity: studies with in vivo microdialysis, Brain Res. 611, 152.
21. 2-mediated behaviour in the 6-hydroxydopamine model of turning: relationship with c-fos expression, J. Pharmacol. Exp. Ther. 290, 402.
22. Nissbrandt, H., E. Pileblad and A. Carlsson, 1985, Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra, J. Pharm. Pharmacol. 37, 884.
23. Nissbrandt, H., E. Sundström, G. Jonsson, S. Hjorth and A. Carlsson, 1989, Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacta, pars reticulata, and striatum, J. Neurochem. 52, 1170.
24. Orosz, D. and J.P. Bennett, 1992, Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the 'hemiparkinsonian' rat, Exp. Neurol. 115, 388.
25. Robertson, G.S. and H.A. Robertson, 1989, Evidence that L-DOPA-induced rotational behavior is dependent on both striatal and nigral mechanisms, J. Neurosci. 9, 3326.
26. Robertson, G.S., G. Damsma and H.C. Fibiger, 1991, Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats, J. Neurosci. 11, 2209.
27. Rothman, R.B., 1994, PCP site 2: a high affinity MK-801-insensitive phencyclidine binding site, Neurotox. Teratol. 16, 343.
28. Santiago, M. and B.H.C. Westerink, 1991, Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats, J. Neurochem. 57, 738.
29. Scatton, B., A. Cheramy, M.J. Besson and J. Glowinski, 1970, Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment, Eur. J. Pharmacol. 13, 131.
30. 2 balance in the basal ganglia and its relevance to Parkinson's disease, Synapse 19, 264.
31. 2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse, Eur. J. Pharmacol. 250, 239.
32. 2 agonist apomorphine, J. Neural Transm. [P-D Sect.] 6, 215.
33. St-Pierre, J.A. and P.J. Bédard, 1994, Intranigral but not intrastriatal microinjection of the NMDA receptor antagonist MK-801 induces contralateral circling in the 6-hydroxydopamine rat model, Brain Res. 660, 255.
34. Svensson, A., E. Pileblad and M. Carlsson, 1991, A comparison between the non-competitive NMDA receptor antagonist dizocilpine (MK-801) and the competitive NMDA receptor antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice, J. Neural Transm. 85, 117.
35. Van Zwieten-Boot, B.J. and E.L. Noach, 1975, The effect of blocking dopamine release on synthesis rate of dopamine in the striatum of the rat, Eur. J. Pharmacol. 33, 247.
36. Wassef, M., A. Berod and C. Sotelo, 1981, Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration, Neuroscience 6, 2125.
37. Whitton, P.S., C.S. Biggs, B.R. Pearce and L.J. Fowler, 1992a, MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo, J. Neurochem. 58, 1573.
38. Whitton, P.S., C.S. Biggs, B.R. Pearce and L.J. Fowler, 1992b, Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis, Neurosci. Lett. 142, 5.
39. Young, A.B. and G.E. Fagg, 1990, Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches, Trends Pharmacol. Sci. 11, 126.
40. Zhang, J., L.A. Chiodo and A.S. Freeman, 1992, Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons, Brain Res. 590, 153.
41. Zhang, J., L.A. Chiodo and A.S. Freeman, 1993, Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl)guanidine on non-dopaminergic mid-brain neurons, Eur. J. Pharmacol. 230, 371.
42. Zhu, M.Y., A.V. Juorio, I.A. Paterson and A.A. Boulton, 1992, Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain, J. Neurochem. 58, 636.